Year(s) | Ischaemic stroke | |||||
Male | Female | Total | ||||
Incidence | n (95% UI) | % (95% UI) | n (95% UI) | % (95% UI) | n (95% UI) | % (95% UI) |
Year 1 to 5 2016–2020 | 1300 (1100–1600) | 7.8 (6.4–9.2) | 1400 (1200–1500) | 6.5 (5.6–7.3) | 2700 (2300–3100) | 7.1 (6.0–8.1) |
Year 1 to 10 2016–2025 | 2800 (2400–3200) | 7.7 (6.6–8.9) | 2800 (2500–3100) | 6.4 (5.7–7.1) | 5600 (5000–6300) | 7.0 (6.2–7.9) |
Year 1 to 15 2016–2030 | 4300 (3700–5000) | 7.6 (6.5–8.7) | 4400 (4000–4800) | 6.3 (5.7–6.9) | 8700 (7800–9700) | 6.9 (6.2–7.7) |
Year 1 to 20 2016–2035 | 5900 (5000–6800) | 7.4 (6.4–8.6) | 6000 (5500–6500) | 6.1 (5.6–6.7) | 11 800 (10 600–13 100) | 6.7 (6.0–7.4) |
Year 1 to 25 2016–2040 | 7300 (6300–8400) | 7.2 (6.2–8.3) | 7500 (6900–8100) | 5.9 (5.4–6.4) | 14 800 (13 400–16 300) | 6.5 (5.9–7.2) |
Year 1 to 30 2016–2045 | 8700 (7400–10 000) | 7.0 (5.9–8.0) | 8900 (8200–9600) | 5.7 (5.2–6.1) | 17 600 (15 800–19 400) | 6.3 (5.6–6.9) |
Lifetime | 10 700 (8800–12 600) | 5.5 (4.5–6.4) | 11 400 (10 300–12 500) | 4.3 (3.9–4.7) | 22 100 (19 400–24 800) | 4.8 (4.2–5.4) |
Mortality | ||||||
Year 1 to 5 2016–2020 | 90 (70–110) | 6.3 (5.0–7.6) | 110 (90–130) | 4.8 (3.9–5.7) | 200 (170–240) | 5.4 (4.4–6.4) |
Year 1 to 10 2016–2025 | 380 (310–450) | 6.5 (5.3–7.7) | 450 (380–520) | 5.0 (4.2–5.7) | 830 (700–960) | 5.6 (4.7–6.5) |
Year 1 to 15 2016–2030 | 800 (700–1000) | 6.6 (5.5–7.7) | 1000 (800–1100) | 5.1 (4.5–5.7) | 1800 (1600–2000) | 5.7 (5.1–6.4) |
Year 1 to 20 2016–2035 | 1400 (1200–1600) | 6.8 (5.6–7.8) | 1600 (1400–1800) | 5.2 (4.6–5.7) | 3000 (2700–3400) | 5.9 (5.3–6.5) |
Year 1 to 25 2016–2040 | 2100 (1800–2400) | 6.7 (5.8–7.8) | 2400 (2200–2600) | 5.2 (4.7–5.7) | 4400 (4000–4900) | 5.8 (5.3–6.4) |
Year 1 to 30 2016–2045 | 2800 (2400–3200) | 6.7 (5.7–7.7) | 3200 (3000–3500) | 5.2 (4.8–5.6) | 6100 (5400–6700) | 5.8 (5.2–6.4) |
Lifetime | 4900 (4000–5800) | 5.3 (4.4–6.3) | 6000 (5400–6600) | 4.1 (3.7–4.5) | 10 900 (9600–12 200) | 4.5 (4.0–5.1) |
UI, uncertainty interval.